A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2016
At a glance
- Drugs Olmesartan medoxomil; Olmesartan medoxomil/rosuvastatin; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- 03 Apr 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.
- 03 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2012 Additional trial identifier KCT0000325 and actual initiation date (18 Jan 2012) identified as reported by Clinical Research Information Service (CriS) - Republic of Korea record.